Search clinical trials for: CCR5 inhibitor,
Total 7980 results
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Kidney DiseasesUnited States
-
Medical College of WisconsinTerminated
-
GlaxoSmithKlineTerminated
-
Merck Sharp & Dohme LLCCompletedAdvanced Breast Cancer | Other Solid Tumors
-
University of California, San DiegoUniversity of California, Los Angeles; Pfizer; University of Southern California and other collaboratorsCompleted
-
University of Maryland, BaltimoreWithdrawnHiv | Kidney Transplant | HIV Reservoir | CCR5United States
-
National Institute of Allergy and Infectious Diseases...Completed
-
China Medical University HospitalCompleted
-
ViiV HealthcarePfizerCompletedCCR5-tropic HIV-1 Infection
-
M.D. Anderson Cancer CenterRigel Pharmaceuticals,Inc.Not yet recruitingMutant IDH1 Inhibitor OlutasidenibUnited States
-
ViiV HealthcarePfizerTerminated
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedHemophilia A or B With InhibitorsCroatia, North Macedonia, Ukraine
-
Rhode Island HospitalCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States
-
Temple UniversityPfizer; AbbottTerminatedHIV InfectionsUnited States
-
Nanjing Medical UniversityCompletedImmune Checkpoint Inhibitor | Endocrine ToxicityChina
-
ViiV HealthcarePfizerCompleted
-
Orion Biotechnology Polska Sp. z o.o.Not yet recruitingMetastatic Colorectal Cancer | Metastatic Cancer | Metastatic Breast Cancer | Metastatic Urothelial Carcinoma | Metastatic Gastric Cancer | Metastatic Pancreatic Cancer
-
Groupe Hospitalier Paris Saint JosephCompleted
-
Merck Sharp & Dohme LLCWithdrawnHIV Infections | Acquired Immunodeficiency Syndrome
-
Sun Yat-sen UniversityRecruitingSolid Tumor | Intestinal Flora | Immune Checkpoint InhibitorChina
-
Centre Hospitalier Intercommunal de Toulon La Seyne...Merck Sharp & Dohme LLC; AbbottCompleted
-
University of California, San FranciscoPfizer; ViiV HealthcareCompleted
-
ViiV HealthcarePfizerCompletedHIV CoinfectionUnited States, Germany, Poland, Spain, Czechia, United Kingdom, Hungary, Puerto Rico, France
-
Sangamo TherapeuticsTerminated
-
American Thrombosis and Hemostasis NetworkTakeda; CSL Behring; OctapharmaCompletedHemophilia A | Hemophilia B | Hemophilia | Hemophilia A With Inhibitor | Haemophilia | Hemophilia B With Inhibitor | Haemophilia A Without Inhibitor | Haemophilia B Without InhibitorUnited States
-
ViiV HealthcarePfizerNo longer available
-
Kevin F. GibsonUniversity of PittsburghTerminatedSarcoidosisUnited States
-
Human Genome Sciences Inc.CompletedHIV InfectionsUnited States
-
Groupe Hospitalier Paris Saint JosephCompletedProton Pump InhibitorFrance
-
Affiliated Hospital to Academy of Military Medical...Peking University; Capital Medical UniversityUnknown
-
Institut Mutualiste MontsourisRecruitingCancer | Cardiovascular Complication | Immune Checkpoint Inhibitor | Immune-related Adverse EventFrance
-
Institut Mutualiste MontsourisInstitut CurieRecruitingCancer | Immune Checkpoint Inhibitor | Cardiovascular BiomarkersFrance
-
Hellenic Cooperative Oncology GroupCompletedAutoimmune Diseases | Immunotherapy | Checkpoint InhibitorGreece
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AKorea, Republic of, United States, France, Germany, Italy, South Africa, Spain, Japan, United Kingdom, Poland, Taiwan, Australia, Costa Rica, New Zealand
-
Ronald BuckanovichGenentech, Inc.RecruitingPARP Inhibitor | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Hedgehog InhibitorUnited States
-
American Thrombosis and Hemostasis NetworkGenentech, Inc.Active, not recruitingHemophilia A With Inhibitor | Hemophilia B With Inhibitor | Haemophilia A Without Inhibitor | Haemophilia B Without InhibitorUnited States
-
Catalyst BiosciencesCompletedHemophilia A | Hemophilia B | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Hemophilia A Without Inhibitor | Hemophilia B Without InhibitorBulgaria, Russian Federation
-
Xiang XieXinjiang Medical UniversityNot yet recruitingCancer | Atherosclerotic Cardiovascular Disease | ASCVD | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
-
GlaxoSmithKlineTerminatedHIV InfectionUnited States, Germany, Belgium, Canada, Denmark
-
Tanta UniversityNot yet recruitingSodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
-
Nanfang Hospital, Southern Medical UniversityRecruitingImmune Checkpoint Inhibitor Associated PneumoniaChina
-
Baxalta now part of ShireBaxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)CompletedAlpha 1-Antitrypsin DeficiencyAustralia, New Zealand
-
Mario Negri Institute for Pharmacological ResearchFederico II University; IRCCS MultimedicaCompletedProton Pump Inhibitor | Primary CareItaly
-
Merck Sharp & Dohme LLCTerminatedColorectal Cancer | Advanced Solid Tumors
-
Puerta de Hierro University HospitalFundación Mutua Madrileña; Instituto de Salud Carlos IIIUnknown
-
PfizerCompletedCarcinoma, Renal Cell | Lymphoma, Mantle-CellSpain
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
PfizerViiV HealthcareCompleted